Gene · 406998
Papers1,352
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,352
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated transcriptomic and regulatory RNA profiling reflects complex pathophysiology and uncovers a conserved gene signature in end stage heart failure. | J Mol Cell Cardiol Plus | 2025 | 40182152 | PubTator, text mining | PubMed |
| Retraction: MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process. | Oncotarget | 2025 | 40063732 | PubTator, text mining | PubMed |
| Serum Exosomal miR-216a Contributes to Acute Pancreatitis-Associated Acute Lung Injury by Enhancing Endothelial Cell Vascular Permeability Through Downregulating LAMC1. | Pancreas | 2025 | 39937877 | PubTator, text mining | PubMed |
| Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development. | Sci Rep | 2025 | 39747972 | PubTator, text mining | PubMed |
| Therapeutic potential of SMAD7 targeting miRNA in the pathogenesis of diabetic nephropathy. | Arch Biochem Biophys | 2025 | 39667550 | PubTator, text mining | PubMed |
| Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models. | BMC Cancer | 2024 | 39448959 | PubTator, text mining | PubMed |
| The Association Between Anti-Neoplastic Effects of Curcumin and Urogenital Cancers: A Systematic Review. | Biomed Res Int | 2024 | 39445208 | PubTator, text mining | PubMed |
| Establishment and assessment of an oral squamous cell carcinoma N7-methylguanosine methyltransferase associated microRNA prognostic model. | J Cancer | 2024 | 39440068 | PubTator, text mining | PubMed |
| Polymorphisms in miRNA Genes Targeting the AMPK Signaling Pathway are Associated with Cervical Cancer Susceptibility in a Han Chinese Population. | Int J Gen Med | 2024 | 39308972 | PubTator, text mining | PubMed |
| Analysis of extracellular vesicle microRNA profiles reveals distinct blood and lymphatic endothelial cell origins. | J Extracell Biol | 2024 | 38938681 | PubTator, text mining | PubMed |
| AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment. | Sci Rep | 2024 | 38802416 | PubTator, text mining | PubMed |
| Decreased Serum Levels of the Insulin Resistance-Related microRNA miR-320a in Patients with Polycystic Ovary Syndrome. | Curr Issues Mol Biol | 2024 | 38666942 | PubTator, text mining | PubMed |
| Whole transcriptome sequencing analyses of islets reveal ncRNA regulatory networks underlying impaired insulin secretion and increased β-cell mass in high fat diet-induced diabetes mellitus. | PLoS One | 2024 | 38557554 | PubTator, text mining | PubMed |
| Homocysteine metabolites inhibit autophagy by upregulating miR-21-5p, miR-155-5p, miR-216-5p, and miR-320c-3p in human vascular endothelial cells. | Sci Rep | 2024 | 38531978 | PubTator, text mining | PubMed |
| Integrated analysis and validation of ferroptosis-related genes and immune infiltration in acute myocardial infarction. | BMC Cardiovasc Disord | 2024 | 38402377 | PubTator, text mining | PubMed |
| Substance basis and pharmacological mechanism of heat-clearing herbs in the treatment of ischaemic encephalopathy: a systematic review and network pharmacology. | Ann Med | 2024 | 38285889 | PubTator, text mining | PubMed |
| Interaction between long noncoding RNA and microRNA in lung inflammatory diseases. | Immun Inflamm Dis | 2024 | 38270295 | PubTator, text mining | PubMed |
| p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy. | Cancers (Basel) | 2024 | 38254747 | PubTator, text mining | PubMed |
| MALAT1 promotes FOXA1 degradation by competitively binding to miR-216a-5p and enhancing neuroendocrine differentiation in prostate cancer. | Transl Oncol | 2024 | 38235618 | PubTator, text mining | PubMed |
| Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions. | Cancer Cell Int | 2024 | 38200584 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406998/papers?page=2